EXHIBIT 23.1




                       CONSENT OF INDEPENDENT ACCOUNTANTS




We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-2) and related prospectus of Molecular
Diagnostics, Inc. (formerly Ampersand Medical Corporation) and Subsidiaries for
the registration of 30,415,328 shares of its common stock and to the
incorporation by reference therein of our report dated March 9, 2001, with
respect to the consolidated financial statements and schedule of Molecular
Diagnostics, Inc. and Subsidiaries included in its Annual Report on Form 10-K,
as amended, for the year ended December 31, 2000, filed with the Securities and
Exchange Commission.






Chicago, Illinois
February 27, 2002